EI
RYTM icon

EFG International’s Rhythm Pharmaceuticals RYTM Stock Holding History

EFG International’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.98M Buy
34,214
+4,923
+17% +$479K 0.06% 272
2025
Q4 		$3.14M Buy
+29,291
New +$3.11M 0.06% 271

Other funds holding RYTM

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

EFG International's RYTM Position: Q1 2026 in Review

EFG International increased its Rhythm Pharmaceuticals (RYTM) stake by 17% in Q1 2026, buying an estimated $479K and bringing the position to 34,214 shares worth $2.98M. The position accounts for 0.06% of the portfolio, ranked #272.

EFG International first reported a position in RYTM in Q4 2025 and has held it in 2 quarters since. The position peaked at $3.14M in Q4 2025. 285 funds tracked by Wall St. Rank hold RYTM as of Q1 2026.

  • EFG International held 34,214 shares of Rhythm Pharmaceuticals worth $2.98M as of Q1 2026.
  • EFG International bought 4,923 Rhythm Pharmaceuticals shares in Q1 2026, an estimated $479K.
  • Rhythm Pharmaceuticals made up 0.06% of EFG International's portfolio in Q1 2026, its #272 holding.
  • EFG International first reported a position in Rhythm Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
  • EFG International's Rhythm Pharmaceuticals position peaked at $3.14M in Q4 2025.
  • 285 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q1 2026.

Based on EFG International's 13F filing for Q1 2026, filed 15 May 2026.